Macau DSSA registration b5e822ec83af302279c96cc537f60c69

SARS-COV-2 NUCLEOCASPID (N) ANTIGEN RAPID DETECTION KIT (COLLOIDAL GOLD METHOD) ANTIGEN SELF TEST

Macau·Brand: SYNTHGENE·Nanjing Synthgene Medical Technology Co., Ltd., China·Updated Mar 20, 2024

Registration details

Registration ID: b5e822ec83af302279c96cc537f60c69
Product Name: SARS-COV-2 NUCLEOCASPID (N) ANTIGEN RAPID DETECTION KIT (COLLOIDAL GOLD METHOD) ANTIGEN SELF TEST
Brand: SYNTHGENE
Last Updated: Mar 20, 2024

Manufacturer information

Manufacturer: Nanjing Synthgene Medical Technology Co., Ltd., China
Country of Origin: China
Local: 中國

Importer contact information

Importer Telephone: 創憶健康科技有限公司:62857555
Importer Telephone (English): TRENDYI TECNOLOGIA E SAÚDE LIMITADA:62857555

About this record

Access comprehensive regulatory information for SARS-COV-2 NUCLEOCASPID (N) ANTIGEN RAPID DETECTION KIT (COLLOIDAL GOLD METHOD) ANTIGEN SELF TEST in Aomen (Macau SAR)'s medical device market through Pure Global AI's free database. This medical device is registered under DSSA identification b5e822ec83af302279c96cc537f60c69 and manufactured by Nanjing Synthgene Medical Technology Co., Ltd., China from China. The device is marketed under the brand name SYNTHGENE.Last updated on Mar 20, 2024.

This page provides complete registration details. Pure Global AI offers free access to 110+ Macau medical device registrations, helping global MedTech companies navigate DSSA regulations and discover market opportunities efficiently.